TABLE 6.
Comorbidity at baseline in the WIHS cohort
| Parameter or conditiona | % Comorbidity
|
|
|---|---|---|
| Original cohort (1994-1995) | Expansion cohort (2001-2002) | |
| HBV core antibodies | 43 | 19 |
| HBV surface antigen | 2.6 | 1.4 |
| HCV antibodies | 39 | 13 |
| SIL on Pap testa | 13 | 8 |
| Diabetes | 4.4 | 4.6 |
| Hypertension | 17 | 12 |
| Obesity | 53 | 65 |
| Smoking | 58 | 42 |
a
HBV, hepatitis B virus; HCV, hepatitis C virus; SIL, squamous intraepithelial lesion. Low-grade SIL, high-grade SIL, or carcinomas were detected in situ on initial Pap smear. Obesity defined as a body mass index of >25.